Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombotic therapy for cervical artery dissection.

S Engelter1, P Lyrer

  • 1Neurological Clinic and Stroke Unit, University Hospital Basel, Basel, Switzerland.

Frontiers of Neurology and Neuroscience
|February 10, 2007
PubMed
Summary

Antithrombotic therapy for cervical artery dissection (CAD) lacks evidence. Clinicians should tailor antiplatelet or anticoagulant choices based on individual patient factors until further research emerges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The quest for indicators of paroxysmal atrial fibrillation in sinus rhythm - the DETECT AF trial.

Acta cardiologica·2018
Same author

Serum neurofilament light chain in patients with acute cerebrovascular events.

European journal of neurology·2017
Same author

Intravenous thrombolysis in stroke patients receiving rivaroxaban.

European journal of neurology·2014
Same author

Etiology of first-ever ischaemic stroke in European young adults: the 15 cities young stroke study.

European journal of neurology·2013
Same author

[The new anticoagulants - their role in secondary prevention of thromboembolism after stroke].

Therapeutische Umschau. Revue therapeutique·2012
Same author

[Endovascular treatment for carotid artery stenosis].

Therapeutische Umschau. Revue therapeutique·2012

Area of Science:

  • Neurology
  • Vascular Medicine
  • Clinical Therapeutics

Background:

  • Antithrombotic therapy for cervical artery dissection (CAD) is currently based on empiric practices rather than robust evidence.
  • The optimal antithrombotic strategy for CAD patients remains undetermined, highlighting a significant gap in clinical guidelines.

Purpose of the Study:

  • To critically evaluate the existing pathophysiological arguments for and against anticoagulation versus antiplatelet therapy in cervical artery dissection.
  • To provide a framework for clinicians to make individualized treatment decisions in the absence of definitive evidence.

Main Methods:

  • Review and synthesis of pathophysiological data supporting or refuting the use of anticoagulants and antiplatelets in CAD.
  • Analysis of clinical and paraclinical features that may inform treatment selection.

Main Results:

  • No consensus exists on routine anticoagulation for all CAD patients.
  • Arguments for and against both anticoagulants and antiplatelets are presented, emphasizing the need for personalized approaches.

Conclusions:

  • A large-scale randomized controlled trial is needed but is a significant undertaking, suggesting a near-term lack of definitive answers.
  • Until further data are available, individualized treatment decisions based on patient-specific factors are recommended for antithrombotic therapy in CAD.

Related Experiment Videos